ebastin teva 10 mg orodisperzibilne tablete
teva pharma b.v. - ebastin - orodisperzibilna tableta - ebastin 10 mg / 1 tableta - ebastin
ebastin teva 20 mg orodisperzibilne tablete
teva pharma b.v. - ebastin - orodisperzibilna tableta - ebastin 20 mg / 1 tableta - ebastin
ebastin teva 20 mg orodisperzibilne tablete
teva pharma b.v. - ebastin - orodisperzibilna tableta - ebastin 20 mg / 1 tableta - ebastin
ebastin teva 10 mg orodisperzibilne tablete
teva pharma b.v. - ebastin - orodisperzibilna tableta - ebastin 10 mg / 1 tableta - ebastin
sporanox 100 mg trde kapsule
johnson & johnson d.o.o. - itrakonazol - kapsula, trda - itrakonazol 100 mg / 1 kapsula - itrakonazol
daktarin 20 mg/g oralni gel
krka, d.d., novo mesto - mikonazol - oralni gel - mikonazol 20 mg / 1 g - mikonazol
sporanox 100 mg trde kapsule
johnson & johnson d.o.o. - itrakonazol - kapsula, trda - itrakonazol 100 mg / 1 kapsula - itrakonazol
sporanox 10 mg/ml peroralna raztopina
johnson & johnson d.o.o. - itrakonazol - peroralna raztopina - itrakonazol 100 mg / 10 ml - itrakonazol
sporanox 100 mg trde kapsule
johnson & johnson d.o.o. - itrakonazol - kapsula, trda - itrakonazol 100 mg / 1 kapsula - itrakonazol
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastična sredstva - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.